Despite the lack of deep value, there is something else: Mirum Pharmaceuticals Inc (MIRM) Stock
H.C. Wainwright lowered the price target for the Mirum Pharmaceuticals Inc (NASDAQ:MIRM) stock to “a Buy”. The rating was released on December 18, 2023, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $60. The stock was initiated by Cantor Fitzgerald, who disclosed […]
Why Mirum Pharmaceuticals Inc (NASDAQ:MIRM) Stock declined -15.05% in Last Three Months?
H.C. Wainwright lowered the price target for the Mirum Pharmaceuticals Inc (NASDAQ:MIRM) stock to “a Buy”. The rating was released on December 18, 2023, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $60. The stock was initiated by Cantor Fitzgerald, who disclosed […]
The growth of Mirum Pharmaceuticals Inc (MIRM) Stock is expected to continue
H.C. Wainwright lowered the price target for the Mirum Pharmaceuticals Inc (NASDAQ:MIRM) stock to “a Buy”. The rating was released on December 18, 2023, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $60. The stock was initiated by Cantor Fitzgerald, who disclosed […]
